On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.
Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...